Skip to main content
Erschienen in: Intensive Care Medicine 12/2007

Open Access 01.12.2007 | Pediatric Brief Report

High incidence of acute lung injury in children with Down syndrome

verfasst von: M. Bruijn, L. B. van der Aa, R. R. van Rijn, A. P. Bos, J. B. M. van Woensel

Erschienen in: Intensive Care Medicine | Ausgabe 12/2007

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Objective

Acute respiratory tract infection is a common reason for hospitalization in children with Down syndrome (CDS) and is characterized by a high morbidity. The severe course of disease in CDS may be related to a higher incidence of acute lung injury (ALI). This study evaluated the incidence of ALI and acute respiratory distress syndrome (ARDS) in mechanically ventilated CDS.

Design and setting

Retrospective cohort study in a pediatric ICU.

Patients and participants

Cases were all mechanically ventilated CDS admitted to our unit between January 1998 and July 2005. All mechanically ventilated patients without Down syndrome from January 1998 to January 2001 served as controls. Postoperative patients (cases and controls) and those with a cardiac left to right shunt were excluded.

Measurements and results

The main outcome measure was the incidence of ALI and ARDS. The criteria for ALI were met in 14 of 24 CDS (58.3%) in 41 of 317 of controls (12.9%; OR 9.4, 95% CI 3.9–22.6). The criteria for ARDS were met in 11 of 24 CDS (46%) and in 21 of 317 of controls (7%; OR 11.9, 95% CI 4.8–29.8). None of the CDS with ALI died; in the control group ten patients with ALI died.

Conclusions

CDS had a significantly higher incidence of ALI and ARDS than children without Down syndrome. The explanation for this remains to be elucidated; further study is necessary before clinical implications become clear.

Introduction

Down syndrome (DS) is the most common chromosomal abnormality and occurs in 1 of 800 live births [1]. Although survival beyond the first year of life has increased considerably in recent decades, children with DS (CDS) still have a shorter life expectancy than those without DS [2]. Acute respiratory tract infection is a common reason for hospitalization in CDS and is characterized by high morbidity [3]. In children with DS it has been suggested to be related to pharyngeal incoordination predisposing to aspiration in combination with concomitant immunodeficiencies [4, 5]. High morbidity in CDS with respiratory disease may also be related to a higher incidence of acute lung injury (ALI). The aim of this study was to evaluate the incidence of ALI and acute respiratory distress syndrome (ARDS) in children with DS who were admitted to the pediatric intensive care unit (PICU) and needed mechanical ventilation. Preliminary data from this study were presented at the 35th Congress of the Society of Critical Care Medicine [6].

Methods

This study compared the occurrence of ALI/ARDS in two groups of patients requiring mechanical ventilation because of respiratory insufficiency. The first group consisted of all 24 consecutive children with genetically confirmed DS admitted to our PICU for mechanical ventilation between January 1998 and July 2005. The second group consisted of all 317 mechanically ventilated children without DS admitted to our PICU between January 1998 and January 2001. Baseline characteristics for CDS and the control group are shown in Table 1. The PICU at Emma Children's Hospital is a 16-bed, tertiary, multidisciplinary unit serving the greater Amsterdam area. Data on the incidence rate of ALI/ARDS in the second group have been published previously [7]. In both groups patients who were admitted for postoperative care directly following a surgical procedure, and those with a cardiac left to right shunt were excluded. Patients were retrospectively evaluated for ALI/ARDS during the second 24 h after admission according to the American–European Consensus Conference criteria [8]. Gas exchange criteria for ALI and ARDS were considered to be met if the PaO2/FIO2 ratio was less than 40.0 kPa for ALI and less than 26.7 kPa for ARDS in at least two consecutive measurements (> 8 h apart). A radiologist blinded to clinical information reviewed the chest radiographs for the presence of bilateral infiltrates. The presence of left heart failure was assessed based on echocardiographic results and/or clinical information. Disease severity on admission was expressed by the Pediatric Risk of Mortality (PRISM) II score, which depends on diagnosis and clinical parameters in the first 24 h of admission [9]. Sepsis was defined as systemic inflammatory response syndrome in the presence of clinical evidence for infection. Lower respiratory tract infection was defined as clinical infection with radiological evidence of alveolar consolidation. Upper respiratory tract infection was defined as infection of the oral and nasal airways, larynx, trachea, and/or bronchi without signs of lower respiratory tract infection.
Table 1
Baseline patient characteristics and cause for respiratory failure
 
Down syndrome (n = 24)
Control group (n = 317)
p
Median age (months; range)
15.2 (0–127.2)
6.1 (0–217.7)
0.39 c
Males
14 (58.3%)
199 (62.8%)
0.67 d
Median PRISM II score (range)
13.5 (0–40)
9.0 (0–47)
0.19 c
Sepsis
3 (12.5%)
52 (16.4%)
0.78 e
Lower respiratory tract infection
18 (75%)
130 (41%)
0.001 d
Upper respiratory tract infection
1 (4.2%)
23 (7.3%)
0.96 e
Congenital heart disease
1 (4.2%)
22 (6.9%)
0.99 e
CNS disorders a
0
53 (16.7%)
0.04 e
Other b
1 (4.2%)
37 (11.7%)
0.50 e
aCNS disorders: convulsions, infections, asphyxia, contusion, cerebral hemorrhage; bOthers, e. g., trauma, cardiomyopathies, electrolyte disturbances, metabolic disease; c Mann–Whitney test; d Pearson's χ2 test; e Fisher's exact test
The comparability of patient characteristics for both groups was tested by means of a chi-square test or Fisher exact test for dichotomous data and a Mann–Whitney U test for continuous data that were not normally distributed. The association between DS and ALI/ARDS was expressed as an odds ratio (OR) with 95% Confidence Interval (CI). Other well known cause for ALI/ARDS and thus possible confounders for the incidence of ALI/ARDS among CDS were identified [8, 10] and evaluated with bivariate logistic regression analysis. Statistical significance was set at 5%.

Results

The criteria for ALI were met in 14 of 24 CDS (58.3%) and in 41 of 317 controls (12.9%; odds ratio 9.4, 95% confidence interval 3.9–22.6). The criteria for ARDS were met in 11 of 24 CDS (46%) and in 21 of 317 controls (7%; odds ratio 11.9, 95% confidence interval 4.8–29.8). There were no deaths in the CDS. In the control group ten patients with ALI died during admission to the PICU. The results of the logistic regression analyses are presented in Table 2. The odds for the incidence of ALI in CDS were hardly altered by adjusting disease severity (PRISM II score), lower respiratory tract infection, or sepsis.
Table 2
Estimated odds ratio (OR) for ALI (Down/control) after adjustment for possible confounders (CI, confidence interval)
Possible confounder
OR
95% CI
None
9.4
3.9–22.6
PRISM II score
9.6
3.9–23.6
Sepsis
12.2
4.9–30.6
Lower respiratory tract infection
10.8
4.3–26.9
We excluded patients who died in the first 24 h after admission. This might have caused a selection bias. Therefore PICU deaths during the first 24 h of admission were analyzed for ALI/ARDS: 36 in the control group, none of whom met the ALI/ARDS criteria. No CDS died in the first 24 h after admission. Thus the odds of developing ALI in CDS are about 9 times those in controls, and this cannot be attributed to the presence of confounders.

Discussion

This study found a very high incidence of 58% of ALI and 46% of ARDS in mechanically ventilated children with DS. This is significantly higher than the incidence of 13% of ALI and 7% of ARDS in the general pediatric population on mechanical ventilation in our unit. Likewise, Randolph et al. [11] reported an incidence of ARDS of almost 8% in a mechanically ventilated pediatric population.
The results of this study need to be interpreted with caution due to the retrospective design and the relatively low number of CDS. The results need to be confirmed in a prospective multicenter study in a larger cohort. Due to the small number of CDS admitted annually to our unit we included CDS for a longer period of time (1998–2005) than the control group (1998–2001). This may interfere with the comparability of the study groups. However, medical care on our unit did not change substantially during this extended period. In both study periods respiratory care was based on the same clinical protocols with a low tidal volume ventilation strategy. Identical ventilators were used. In addition, the disease severity (expressed as mean PRISM II scores) did not differ between 2001–2005 and 1998–2001. Therefore we have no reason to assume that the incidence of ALI in mechanically ventilated patients changed substantially during the 2001–2005 period.
Despite the high incidence of ALI/ARDS we found no mortality in our population of CDS. Others have reported a mortality rate of almost 5% in children with ARDS [11, 12]. Although this remains speculative, it is possible that CDS are more susceptible to progression to ALI/ARDS despite less severe underlying conditions, without concomitant mortality. In addition, there were only three patients with sepsis and none with trauma as underlying cause of ALI/ARDS in the CDS group, conditions associated with a high mortality rate. However, ALI/ARDS is associated with high morbidity in CDS. The need for ventilatory support was 21 ± 21 days in CDS with ALI vs. 8 ± 5 days in CDS without ALI (p = 0.03). Long-term effects of ALI on morbidity in CDS are unknown and remain to be defined by lung function measurements. The high mortality rate among patients with ALI in the control group might be explained by the relatively high number of patients (n = 4) with severe cerebral damage. This has been shown to be a strong predictor for mortality in ALI [13].
The mechanism leading to the high incidence of ALI in CDS remains uncertain. Initial ventilator settings have recently been shown to be a risk factor for the development of ARDS [14]. In this single-center study the ventilatory strategies for CDS did not differ from those in other patients and were based on the same low tidal volume protocol. Recently it has been shown that apoptosis or programmed cell death plays a pivotal role in the pathogenesis of injurious states of the pulmonary system such as of ALI/ARDS [15, 16]. The higher incidence of ALI/ARDS may be caused by an elevated rate of apoptosis in CDS. An enhanced level of apoptosis in DS has been shown in several cells including neurons [17, 18], thymocytes [19], and granulocytes [20]. It has been suggested that increased apoptosis in DS cells is related to an inability to deal with oxidative stress, leading to accumulation of reactive oxygen radicals [21]. One could speculate whether this is related to an imbalance in the antioxidant/oxidant status in patients with DS due to increased levels of superoxide dismutase 1, an important enzyme in the antioxidant pathway that is encoded for on chromosome 21 [22, 23]. To what extent this is associated with an increased susceptibility to develop ALI/ARDS deserves further investigation. From this point of view our findings are not only of scientific interest but may also be of clinical relevance. For example, ventilatory strategies or oxygen therapy might need to be reevaluated and adjusted for CDS.
In conclusion, we found an unexpected high incidence of ALI and ARDS in CDS. The explanation for these findings remains to be elucidated.

Acknowledgements

The authors thank J. H. van der Lee (Department of Pediatric Clinical Epidemiology, Emma Children's Hospital) for her contribution to the statistical analysis of the data. None of the authors had any conflict of interests, and there was no financial support.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 2.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

e.Med Anästhesiologie

Kombi-Abonnement

Mit e.Med Anästhesiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes AINS, den Premium-Inhalten der AINS-Fachzeitschriften, inklusive einer gedruckten AINS-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Anonymous (2006) Improved national prevalence estimates for 18 selected major birth defects—United States, 1999–2001. MMWR Morb Mortal Wkly Rep 54:1301–1305 Anonymous (2006) Improved national prevalence estimates for 18 selected major birth defects—United States, 1999–2001. MMWR Morb Mortal Wkly Rep 54:1301–1305
2.
Zurück zum Zitat Yang Q, Rasmussen SA, Friedman JM (2002) Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population based study. Lancet 359:1019–1025PubMedCrossRef Yang Q, Rasmussen SA, Friedman JM (2002) Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population based study. Lancet 359:1019–1025PubMedCrossRef
3.
Zurück zum Zitat Hilton JM, Fitzgerald DA, Cooper DM (1999) Respiratory morbidity of hospitalized children with trisomy 21. J Paediatr Child Health 35:383–386PubMedCrossRef Hilton JM, Fitzgerald DA, Cooper DM (1999) Respiratory morbidity of hospitalized children with trisomy 21. J Paediatr Child Health 35:383–386PubMedCrossRef
4.
Zurück zum Zitat Zarate N, Mearin F, Hidalgo A, Malagelada JR (2001) Prospective evaluation of esophageal motor dysfunction in Down's syndrome. Am J Gastroenterol 96:1718–1724PubMed Zarate N, Mearin F, Hidalgo A, Malagelada JR (2001) Prospective evaluation of esophageal motor dysfunction in Down's syndrome. Am J Gastroenterol 96:1718–1724PubMed
5.
Zurück zum Zitat De Hingh YCM, Van der Vossen PW, Gemen EF, Mulder AB, Hop WC, Brus F, de Vries E (2005) Intrinsic Abnormalities of Lymphocyte Counts in Children with Down Syndrome. J Pediatr 147:744–747PubMedCrossRef De Hingh YCM, Van der Vossen PW, Gemen EF, Mulder AB, Hop WC, Brus F, de Vries E (2005) Intrinsic Abnormalities of Lymphocyte Counts in Children with Down Syndrome. J Pediatr 147:744–747PubMedCrossRef
6.
Zurück zum Zitat Van der Aa LB, Bos AP, van Rijn RR, van Woensel JB (2005) Acute lung injury in patients with Down syndrome. Proceedings 35th Society of Critical Care Medicine Congress. Crit Care Med 33:A123 Van der Aa LB, Bos AP, van Rijn RR, van Woensel JB (2005) Acute lung injury in patients with Down syndrome. Proceedings 35th Society of Critical Care Medicine Congress. Crit Care Med 33:A123
7.
Zurück zum Zitat Dahlem P, van Aalderen WM, Hamaker ME, Dijkgraaf MG, Bos AP (2003) Incidence and short-term outcome of acute lung injury in mechanically ventilated children. Eur Respir J 22:980–985PubMedCrossRef Dahlem P, van Aalderen WM, Hamaker ME, Dijkgraaf MG, Bos AP (2003) Incidence and short-term outcome of acute lung injury in mechanically ventilated children. Eur Respir J 22:980–985PubMedCrossRef
8.
Zurück zum Zitat Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spraqq R (1994) Report of the American–European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med 20:225–232PubMedCrossRef Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spraqq R (1994) Report of the American–European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med 20:225–232PubMedCrossRef
9.
Zurück zum Zitat Pollack MM, Ruttiman UE, Getson PR (1986) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116CrossRef Pollack MM, Ruttiman UE, Getson PR (1986) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116CrossRef
10.
Zurück zum Zitat Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349PubMedCrossRef Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349PubMedCrossRef
11.
Zurück zum Zitat Randolph AG, Meert KL, O'Neill ME et al. (2003) The feasibility of conducting clinical trials in infants and children with acute respiratory failure. Am J Respir Crit Care Med 167:1334–1340PubMedCrossRef Randolph AG, Meert KL, O'Neill ME et al. (2003) The feasibility of conducting clinical trials in infants and children with acute respiratory failure. Am J Respir Crit Care Med 167:1334–1340PubMedCrossRef
12.
Zurück zum Zitat Curley MA, Thompson JE, Arnold JH (2000) The effects of early and repeated prone positioning in pediatric patients with acute lung injury. Chest 118:156–163PubMedCrossRef Curley MA, Thompson JE, Arnold JH (2000) The effects of early and repeated prone positioning in pediatric patients with acute lung injury. Chest 118:156–163PubMedCrossRef
13.
Zurück zum Zitat Flori HR, Glidden DV, Rutherford GW, Matthay MA (2005) Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med 171:995–1001PubMedCrossRef Flori HR, Glidden DV, Rutherford GW, Matthay MA (2005) Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med 171:995–1001PubMedCrossRef
14.
Zurück zum Zitat Gajic O, Frutos-Vivar F, Esteban A, Hubmayr RD, Anzueto A (2005) Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients. Intensive Care Med 31:922–926PubMedCrossRef Gajic O, Frutos-Vivar F, Esteban A, Hubmayr RD, Anzueto A (2005) Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients. Intensive Care Med 31:922–926PubMedCrossRef
15.
Zurück zum Zitat Martin TR, Nakamura M, Matute-Bello G (2003) The role of apoptosis in acute lung injury. Crit Care Med 31:S184–S188PubMedCrossRef Martin TR, Nakamura M, Matute-Bello G (2003) The role of apoptosis in acute lung injury. Crit Care Med 31:S184–S188PubMedCrossRef
16.
Zurück zum Zitat Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, Zimmerman GA, Matthay MA, Ware LB (2002) Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 161:1783–1796PubMed Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, Zimmerman GA, Matthay MA, Ware LB (2002) Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 161:1783–1796PubMed
17.
Zurück zum Zitat Sawa A (1999) Neuronal cell death in Down's syndrome. J Neural Transm Suppl 57:87–97PubMed Sawa A (1999) Neuronal cell death in Down's syndrome. J Neural Transm Suppl 57:87–97PubMed
18.
Zurück zum Zitat Seidl R, Bidmon B, Bajo M, Yoo PC, Cairns N, LaCasse EC, Lubec G (2001) Evidence for apoptosis in the fetal Down syndrome brain. J Child Neurol 16:438–442PubMedCrossRef Seidl R, Bidmon B, Bajo M, Yoo PC, Cairns N, LaCasse EC, Lubec G (2001) Evidence for apoptosis in the fetal Down syndrome brain. J Child Neurol 16:438–442PubMedCrossRef
19.
Zurück zum Zitat Levin S, Schlesinger M, Handzel Z, Hahn T, Altman Y, Czernobilsky B, Boss J (1979) Thymic deficiency in Down's syndrome. Pediatrics 63:80–87PubMed Levin S, Schlesinger M, Handzel Z, Hahn T, Altman Y, Czernobilsky B, Boss J (1979) Thymic deficiency in Down's syndrome. Pediatrics 63:80–87PubMed
20.
Zurück zum Zitat Yasui K, Shinozaki K, Nakazawa T, Agematsu K, Komiyama A (1999) Presenility of granulocytes in Down syndrome individuals. Am J Med Genet 84:406–412PubMedCrossRef Yasui K, Shinozaki K, Nakazawa T, Agematsu K, Komiyama A (1999) Presenility of granulocytes in Down syndrome individuals. Am J Med Genet 84:406–412PubMedCrossRef
21.
Zurück zum Zitat Helguera P, Pelsman A, Pigino G, Wolvetang E, Head E, Busciglio J (2005) Ets-2 Promotes the Activation of a Mitochondrial Death Pathway in Down's Syndrome Neurons. J Neurosci 25:2295–2303PubMedCrossRef Helguera P, Pelsman A, Pigino G, Wolvetang E, Head E, Busciglio J (2005) Ets-2 Promotes the Activation of a Mitochondrial Death Pathway in Down's Syndrome Neurons. J Neurosci 25:2295–2303PubMedCrossRef
22.
Zurück zum Zitat Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378:776–779PubMedCrossRef Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378:776–779PubMedCrossRef
23.
Zurück zum Zitat Gulesserian T, Engidawork E, Fountoulakis M, Lubec G (2001) Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome. J Neural Transm Suppl 61:71–84PubMed Gulesserian T, Engidawork E, Fountoulakis M, Lubec G (2001) Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome. J Neural Transm Suppl 61:71–84PubMed
Metadaten
Titel
High incidence of acute lung injury in children with Down syndrome
verfasst von
M. Bruijn
L. B. van der Aa
R. R. van Rijn
A. P. Bos
J. B. M. van Woensel
Publikationsdatum
01.12.2007
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 12/2007
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-007-0803-z

Weitere Artikel der Ausgabe 12/2007

Intensive Care Medicine 12/2007 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.